Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells. (scientific article published on 8 October 2008)

N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.

Q33301354

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

Q33783647

A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts

Q34554484

Present and future treatment of pancreatic cancer

Q34718249

The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

Q36644183

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

Q36694528

Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4.

Q36899101

Diet and pancreatic cancer: a case-control study

Q38592134

Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.

Q40178385

Interaction between doxorubicin and the resistance modifier stilbene on multidrug resistant mouse lymphoma and human breast cancer cells

Q40210344

Anti-mitotic properties of resveratrol analog (Z)-3,5,4'-trimethoxystilbene

Q40225378

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

Q40371567

Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines

Q40866080

Treatment of pancreatic cancer: current limitations, future possibilities

Q40947607

Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells

Q41021779

In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub).

Q41574653

Differential cytotoxicity of combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines

Q41749677

Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas.

Q43608910

Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.

Q43640339

DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia

Q43746938

Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells

Q44200538

Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization

Q44569587

Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship

Q45090641

Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells

Q45249210

Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship.

Q45302719

Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors.

Q51737724

Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines.

Q53343691

Role of ribonucleotide reductase in expression in the neoplastic program.

Q53571837

Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance

Q56610830

Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase

Q57909898

Wine Antioxidant Polyphenols Inhibit the Proliferation of Human Prostate Cancer Cell Lines

Q58239713

Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells

Q74163308

Resveratrol, a remarkable inhibitor of ribonucleotide reductase

Q74191674

Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate

Q77394912

Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells

Q77402133

Reactivity studies of the tyrosyl radical in ribonucleotide reductase from Mycobacterium tuberculosis and Arabidopsis thaliana--comparison with Escherichia coli and mouse

Q77750948

P433

issue

P921

main subject

pancreatic carcinoma

Q18556536

P304

page(s)

393-401

P577

publication date

2008-10-08

P1433

published in

Investigational New Drugs

Q2312231

P1476

title

Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells

P478

volume

Reverse relations

cites work (P2860)

Q39638532	Antiproliferative effect of resveratrol in pancreatic cancer cells
Q34695119	Chemosensitization of tumors by resveratrol
Q39110541	Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.
Q47614745	Elastographic Assessment of Xenograft Pancreatic Tumors
Q28552026	Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides
Q36763100	Pancreatic cancer chemoprevention by phytochemicals
Q38568979	Resveratrol in the treatment of pancreatic cancer.
Q41841905	Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer
Q38873022	Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cells
Q39770059	Selective proapoptotic activity of polyphenols from red wine on teratocarcinoma cell, a model of cancer stem-like cell